Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors Peer median
Gross Margin for KARD and competitors
Company Period LTM level YoY 3-year change
TNYATenaya Therapeutics, Inc.LTM Mar 2026144.9% ——
RNAAtrium Therapeutics, Inc.FY2025100.0% ——
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 202692.1% -7.9 pp-0.3 pp
CYTKCytokinetics, IncorporatedLTM Jun 202688.7% -11.3 pp+243.1 pp
KARDKardigan, Inc.—— ——
IKTInhibikase Therapeutics, Inc.FY2025— ——
Peer median (excluding KARD) 96.1%-9.6 pp+121.4 pp

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.